SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Whole-genome sequence-based analysis of thyroid function.

Taylor, PN; Porcu, E; Chew, S; Campbell, PJ; Traglia, M; Brown, SJ; Mullin, BH; Shihab, HA; Min, J; Walter, K; et al. Taylor, PN; Porcu, E; Chew, S; Campbell, PJ; Traglia, M; Brown, SJ; Mullin, BH; Shihab, HA; Min, J; Walter, K; Memari, Y; Huang, J; Barnes, MR; Beilby, JP; Charoen, P; Danecek, P; Dudbridge, F; Forgetta, V; Greenwood, C; Grundberg, E; Johnson, AD; Hui, J; Lim, EM; McCarthy, S; Muddyman, D; Panicker, V; Perry, JRB; Bell, JT; Yuan, W; Relton, C; Gaunt, T; Schlessinger, D; Abecasis, G; Cucca, F; Surdulescu, GL; Woltersdorf, W; Zeggini, E; Zheng, H-F; Toniolo, D; Dayan, CM; Naitza, S; Walsh, JP; Spector, T; Davey Smith, G; Durbin, R; Richards, JB; Sanna, S; Soranzo, N; Timpson, NJ; Wilson, SG; UK0K Consortium (2015) Whole-genome sequence-based analysis of thyroid function. Nat Commun, 6. p. 5681. ISSN 2041-1723 https://doi.org/10.1038/ncomms6681
SGUL Authors: Jamshidi, Yalda

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
[img]
Preview
PDF (Supplementary Information) Published Version
Download (16MB) | Preview

Abstract

Normal thyroid function is essential for health, but its genetic architecture remains poorly understood. Here, for the heritable thyroid traits thyrotropin (TSH) and free thyroxine (FT4), we analyse whole-genome sequence data from the UK10K project (N=2,287). Using additional whole-genome sequence and deeply imputed data sets, we report meta-analysis results for common variants (MAF≥1%) associated with TSH and FT4 (N=16,335). For TSH, we identify a novel variant in SYN2 (MAF=23.5%, P=6.15 × 10(-9)) and a new independent variant in PDE8B (MAF=10.4%, P=5.94 × 10(-14)). For FT4, we report a low-frequency variant near B4GALT6/SLC25A52 (MAF=3.2%, P=1.27 × 10(-9)) tagging a rare TTR variant (MAF=0.4%, P=2.14 × 10(-11)). All common variants explain ≥20% of the variance in TSH and FT4. Analysis of rare variants (MAF<1%) using sequence kernel association testing reveals a novel association with FT4 in NRG1. Our results demonstrate that increased coverage in whole-genome sequence association studies identifies novel variants associated with thyroid function.

Item Type: Article
Additional Information: This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ Correction available at: https://doi.org/10.1038/ncomms8172
Keywords: 3',5'-Cyclic-AMP Phosphodiesterases, Cohort Studies, DNA Methylation, Genetic Association Studies, Genomics, Humans, Synapsins, Thyroid Gland, Thyrotropin, Thyroxine, United Kingdom, UK0K Consortium, Thyroid Gland, Humans, Thyrotropin, Thyroxine, Synapsins, Cohort Studies, Genomics, DNA Methylation, 3',5'-Cyclic-AMP Phosphodiesterases, Genetic Association Studies, United Kingdom, MD Multidisciplinary
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Nat Commun
ISSN: 2041-1723
Language: eng
Dates:
DateEvent
6 March 2015Published
27 October 2014Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
MR/K006215/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MC_UU_12013/3Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
102215Wellcome Trusthttp://dx.doi.org/10.13039/100004440
WT091310Wellcome Trusthttp://dx.doi.org/10.13039/100004440
096599Wellcome Trusthttp://dx.doi.org/10.13039/100004440
MC_U106179472Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
RG/10/17/28553British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
095515Wellcome Trusthttp://dx.doi.org/10.13039/100004440
100574Wellcome Trusthttp://dx.doi.org/10.13039/100004440
UNSPECIFIEDWellcome Trusthttp://dx.doi.org/10.13039/100004440
MR/L010305/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MC_UU_12013/8Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MC_UU_12013/2Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MC_PC_15018Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MC_UU_12015/2Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
098498Wellcome Trusthttp://dx.doi.org/10.13039/100004440
100140Wellcome Trusthttp://dx.doi.org/10.13039/100004440
091551Wellcome Trusthttp://dx.doi.org/10.13039/100004440
PubMed ID: 25743335
Web of Science ID: WOS:000352635000001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/112980
Publisher's version: https://doi.org/10.1038/ncomms6681

Statistics

Item downloaded times since 25 Feb 2021.

Actions (login required)

Edit Item Edit Item